Successful Pilot Study of Final Dose Cannabinoid Capsules
(WorldNews Asia)

ASX RELEASE Successful Pilot Study of Final Dose Cannabinoid Capsules Highlights o AusCann has completed a successful pilot study of an optimal final dose form for its proprietary cannabinoid medicines o New dose form solves the problem of stability of medical cannabis products currently on market o The study was carried out over the past ten months to be ready for the release of AusCann`s first cannabinoid medicines in first half of 2019 o This oral delivery dose form has been developed in the form of a unique solid capsule and a patent has been lodged by AusCann o AusCann has utilised its team of Australian pharmaceutical experts for the formulation and design process o AusCann is...